Reports

Royalty Rates in Pharmaceutical Licensing Deals

This report is a must read for anyone involved in deal making and builds on the excellent reputation achieved from the previous edition of the report. Based on over 15 years' experience of assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making, the report seeks to demystify the subject of royalty rates, answering key questions such as: What royalty rates are used in pharmaceutical agreements? What are the factors that influence royalty rates? How do I calculate and determine royalty rates? How are other organisations setting their royalty rates? With new insight and data, this report will be valuable to past purchasers of the previous edition in addition to new pharmaceutical players, technology transfer staff and VC firms.